SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-227267
Filing Date
2023-09-01
Accepted
2023-09-01 12:00:29
Documents
13
Period of Report
2023-09-01
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d544436d8k.htm   iXBRL 8-K 29582
2 EX-3.1 d544436dex31.htm EX-3.1 7290
  Complete submission text file 0001193125-23-227267.txt   166437

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA harp-20230901.xsd EX-101.SCH 2855
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE harp-20230901_lab.xml EX-101.LAB 18722
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE harp-20230901_pre.xml EX-101.PRE 11707
7 EXTRACTED XBRL INSTANCE DOCUMENT d544436d8k_htm.xml XML 3569
Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38800 | Film No.: 231231445
SIC: 2836 Biological Products, (No Diagnostic Substances)